Corvex regains Nasdaq equity compliance

Corvex, Inc. has regained compliance with Nasdaq’s minimum stockholders’ equity requirement for its common stock listing.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Corvex, Inc. has regained compliance with Nasdaq’s minimum stockholders’ equity requirement for its common stock listing. Nasdaq’s Hearings Panel informed the company on April 7, 2026, that it now meets the Minimum Stockholders’ Equity Rule. The company will be under a Mandatory Panel Monitor for one year starting April 7, 2026, and any new listing-rule violation during this period could lead directly to a new hearing without additional time to regain compliance.

Positive

Nasdaq equity compliance restored: As of April 7, 2026, Corvex is back in compliance with Nasdaq’s Minimum Stockholders’ Equity Rule, removing the immediate threat that its common stock could be suspended or delisted for failing this requirement.

Negative

One-year mandatory monitoring period: Corvex will be under a Mandatory Panel Monitor for one year from April 7, 2026; any new Nasdaq listing-rule violation during this time may proceed directly to a hearing without additional time to cure.

Insights

Corvex regains Nasdaq equity compliance but faces one year of close monitoring.

Corvex, Inc. received confirmation on April 7, 2026 that it is back in compliance with Nasdaq’s Minimum Stockholders’ Equity Rule after previously falling short of the required equity level for continued listing.

The company had been operating under an extension granted by the Nasdaq Hearings Panel through March 30, 2026. The new notice resolves the immediate listing-risk overhang by confirming that its common stock currently satisfies the equity standard for The Nasdaq Capital Market.

Corvex will be subject to a Mandatory Panel Monitor for one year beginning April 7, 2026. Any new listing-rule deficiency during this period can move directly to a hearing without extra compliance-plan time, so ongoing adherence to Nasdaq rules remains critical.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Key Figures

Compliance confirmation date: April 7, 2026 Extension deadline: March 30, 2026 Monitoring period length: One year +1 more

4 metrics

Compliance confirmation date April 7, 2026 Date Nasdaq Panel found Corvex in compliance with Minimum Stockholders’ Equity Rule

Extension deadline March 30, 2026 Prior deadline granted by Nasdaq Hearings Panel to regain equity compliance

Monitoring period length One year Duration of Mandatory Panel Monitor starting April 7, 2026

Initial deficiency notice date October 1, 2025 Date Corvex was first notified of non-compliance with equity requirement

Key Terms

Minimum Stockholders’ Equity Rule, Nasdaq Hearings Panel, Mandatory Panel Monitor, The Nasdaq Capital Market

4 terms

Minimum Stockholders’ Equity Rule financial

"in compliance with the Minimum Stockholders’ Equity Rule"

A minimum stockholders’ equity rule is a requirement that a company keep a certain amount of net worth — the value left after subtracting liabilities from assets — to meet listing standards, loan covenants, or regulatory tests. Investors care because falling below that threshold can trigger warnings, trading restrictions, forced restructurings, or debt defaults; think of it like a bank minimum balance that, if breached, can cause automatic penalties and loss of confidence.

Nasdaq Hearings Panel regulatory

"the Nasdaq Hearings Panel (the “Panel”) notified the Company"

A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.

Mandatory Panel Monitor regulatory

"subject to a Mandatory Panel Monitor for a period of one year"

A mandatory panel monitor is an independent group tasked with regularly reviewing safety and key results during a clinical trial or regulated program to protect participants and ensure the study is conducted properly. For investors, this matters because the panel can recommend changes, pauses, or early stopping of a trial — actions that can speed up, delay, or quietly derail a program and therefore materially affect a company’s timeline and value, much like a referee whose calls change the outcome of a game.

The Nasdaq Capital Market financial

"for the continued listing of the Company’s common stock on The Nasdaq Capital Market"

A tier of the Nasdaq stock exchange that hosts smaller or early-stage public companies that meet defined listing standards for size, share price and governance. Think of it as a particular shelf in a store for emerging brands: it gives investors a centralized place to find and trade these stocks while signaling that the companies meet basic regulatory and financial rules. Investors watch it for growth opportunities and higher volatility compared with larger markets.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Corvex, Inc. (MOVE) announce regarding its Nasdaq listing status?

Corvex, Inc. announced that Nasdaq’s Hearings Panel has found the company back in compliance with the Minimum Stockholders’ Equity Rule as of April 7, 2026. This resolves an earlier deficiency notice related to continued listing on The Nasdaq Capital Market.

Why was Corvex, Inc. previously out of compliance with Nasdaq rules?

Corvex, Inc. had been notified on October 1, 2025, that it did not meet Nasdaq’s minimum stockholders’ equity requirement under Listing Rule 5550(b)(1). This shortfall threatened its continued listing on The Nasdaq Capital Market until compliance was later restored.

What extension had Nasdaq granted Corvex, Inc. to regain equity compliance?

Nasdaq’s Hearings Panel approved Corvex, Inc.’s request for an extension until March 30, 2026, to regain compliance with the Minimum Stockholders’ Equity Rule. This extension period allowed the company time to improve its stockholders’ equity position before the recent favorable determination.

What is the Mandatory Panel Monitor imposed on Corvex, Inc.?

Nasdaq has placed Corvex, Inc. under a Mandatory Panel Monitor for one year starting April 7, 2026. During this period, any new Nasdaq listing-rule violation may go directly to a hearing, without an opportunity to submit a compliance plan or obtain extra cure time.

Could Corvex, Inc. still face suspension or delisting from Nasdaq?

Yes, Corvex, Inc. could still face suspension or delisting if it again violates a Nasdaq Listing Rule during the one-year monitoring period. However, the company would be allowed to request a new hearing with the Nasdaq Hearings Panel before its securities are suspended or delisted.

Which Nasdaq rule did Corvex, Inc. regain compliance with?

Corvex, Inc. regained compliance with Nasdaq Listing Rule 5550(b)(1), known as the Minimum Stockholders’ Equity Rule. This rule sets a minimum stockholders’ equity level that companies on The Nasdaq Capital Market must maintain to keep their common stock listed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/09/2026 - 07:30 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 7, 2026

CORVEX, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-40254

82-4233771

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

3401 North Fairfax Drive, Suite 3230, Arlington, Virginia		22226
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: ((866) GET-GPUS ((866) 438-4787)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		MOVE		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events

As previously disclosed, on October 1, 2025, Corvex, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum stockholders’ equity requirement for the continued listing of the Company’s common stock (the “Common Stock”) on The Nasdaq Capital Market, under Listing Rule 5550(b)(1) (the “Minimum Stockholders’ Equity Rule”).

As previously disclosed, the Nasdaq Hearings Panel (the “Panel”) notified the Company on December 18, 2025, that the Panel had approved the Company’s request for an extension until March 30, 2026, to regain compliance with the Stockholders’ Equity Requirement.

On April 7, 2026, the Company received a letter from Nasdaq stating that Panel has found the Company to be in compliance with the Minimum Stockholders’ Equity Rule. The letter also indicated that the Company will be subject to a Mandatory Panel Monitor for a period of one year commencing on April 7, 2026. If, within that one-year monitoring period, the Staff finds the Company out of compliance with a Nasdaq Listing Rule, the Company will not be afforded the opportunity to provide the Staff with a plan of compliance or permitted additional time to regain compliance. However, the Company will have an opportunity to request a new hearing with the Panel prior to the Company’s securities being suspended or delisted from Nasdaq.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CORVEX, INC.

Date: April 9, 2026	By:	/s/ J Cogan
		J Cogan
		Chief Financial Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Corvex regains Nasdaq equity compliance